To evaluate the cytotoxicity induced by EGF polymeric nanoparticles, we first investigated the cellular responses, mechanism of action, and anti-cancer activities of EGF-NPs with PS as a carrier (EGF-PSNPs) using the HeLa human cervical adenocarcinoma cells. The gene discussed is EGF; the disease is cervical adenocarcinoma.